"chemotherapy by doxorubicin" trang 11 - tải miễn phí từ tailieunhanh
Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
8    52    1
Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases

Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
9    43    2
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: Individual patient data meta-analysis

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: Individual patient data meta-analysis
12    31    1
Inhibition of IGF1-R overcomes IGFBP7- induced chemotherapy resistance in T-ALL

Inhibition of IGF1-R overcomes IGFBP7- induced chemotherapy resistance in T-ALL
12    37    1
Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016

Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016
13    35    1
RACE-trial: Neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

RACE-trial: Neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
9    45    1
Development and validation of oral chemotherapy self-management scale

Development and validation of oral chemotherapy self-management scale
7    44    1
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
8    52    1
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial
9    34    1
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
10    38    1
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: The CHARISMA randomized multicenter clinical trial

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: The CHARISMA randomized multicenter clinical trial
7    44    1
Clinical observations on chemotherapy curable malignancies: Unique genetic events, frozen development and enduring apoptotic potential

Clinical observations on chemotherapy curable malignancies: Unique genetic events, frozen development and enduring apoptotic potential
25    36    1
Adjuvant chemotherapy for stage III colon cancer: Relative dose intensity and survival among veterans

Adjuvant chemotherapy for stage III colon cancer: Relative dose intensity and survival among veterans
13    52    1
Prediction of resistance to chemotherapy in ovarian cancer: A systematic review

Prediction of resistance to chemotherapy in ovarian cancer: A systematic review
32    51    1
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
8    23    1
A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
9    42    1
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer
10    23    1
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: First report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: First report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
14    31    1
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
7    31    1
Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden

Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
7    38    1